Evidence for proteinase-activated receptor-2 (PAR-2)-mediated mitogenesis in coronary artery smooth muscle cells
Evidence for proteinase-activated receptor-2 (PAR-2)-mediated mitogenesis in coronary artery smooth muscle cells
复制标题
DOI:
10.1038/sj.bjp.0702509
复制
发表时间:
1999-04-01
影响因子:
7.3
通讯作者:
Schrör, K
中科院分区:
文献类型:
--
作者:
Bretschneider, E;Kaufmann, R;Schrör, K
1 This study investigates, whether in addition to the thrombin receptor (PAR-1), the proteinase-activated receptor-2 (PAR-2) is present in vascular smooth muscle cells (SMC) and mediates mitogenesis. PAR-2 is activated by low concentrations of trypsin and the synthetic peptide SLIGRL.2 Stimulation of bovine coronary artery SMC by trypsin (2 nM) caused a 3 fold increase in DNLA-synthesis. A similar effect was observed with 10 nM thrombin. Trypsin-induced mitogenesis was inhibited by soybean trypsin inhibitor, indicating that the proteolytic activity of the enzyme was required for its mitogenic effect.3 The specific PAR-2-activating peptide SLIGRL or the PAR1-activating peptide SFFLRN did not elicit mitogenesis.4 When the SMC were exposed to SLIGRL (40 nM), a homologous desensitization of cytosolic Ca2+ mobilization was found after subsequent stimulation with trypsin (40 nM) but not thrombin (15 nM).5 Trypsin (2 nM) as well as SLIGRL (100 mu M) activated the nuclear factor kappa B (NF kappa B) with a maximum response 2 h after stimulation of the SMC. This suggests that both agonists acted via a common receptor, PAR-2. Maximum activation of NF kappa B by thrombin (10 nM) was detected after 4-5 h.6 These data suggest that PAR-2 is present in coronary SMC and mediates a mitogenic response. Activation of NF kappa B via either PAR-1 or PAR-2 does not predict mitogenesis.